Intermittent Tacrolimus Ointment Therapy Helps Prevent Relapse of Stabilized Atopic Dermatitis

kavin submitted, created time 4 months 3 weeks (www.medscape.com)

NEW YORK (Reuters Health) Jun 23 - In patients with stabilized atopic dermatitis, intermittent therapy with tacrolimus ointment was associated with significantly more flare-free days and longer time to first relapse compared with vehicle alone, according to a report in the June issue of the Journal of the American Academy of Dermatology.

Tacrolimus is a topical calcineurin inhibitor (TCI) and is manufactured in ointment form under the brand name Protopic by Astellas Pharma US Inc., which supported this multicenter study by U.S. researchers

2 comments | Blog It | Email It | Keywords: Tacrolimus Ointment Therapy patients dermatology Intermittent Tacrolimus Ointment Therapy atopic dermatitis